Dasatinib and Zocor drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dasatinib (dasatinib) and Zocor (simvastatin). Common drug interactions include encephalocele among males.

The phase IV clinical study analyzes what interactions people have when they take Dasatinib and Zocor. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Dasatinib?

Dasatinib has active ingredients of dasatinib. eHealthMe is studying from 9,407 Dasatinib users. Check the latest studies of Dasatinib.

What is Zocor?

Zocor has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 86,545 Zocor users. Check the latest studies of Zocor.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 17, 2026

11 people who take Dasatinib and Zocor together, and have interactions are studied.

Dasatinib and Zocor drug interactions.

What are the common drug interactions of Dasatinib and Zocor, by gender? *:

female:

n/a

male:

  1. Encephalocele (hernia of the brain that is either congenital or due to trauma)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  3. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  4. Blood creatine increased
  5. Blood urea increased
  6. Cardiac failure
  7. Chest pain
  8. Coronary arterial stent insertion
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Coronary artery stenosis (narrowing of coronary artery)

What are the common drug interactions of Dasatinib and Zocor, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Encephalocele (hernia of the brain that is either congenital or due to trauma)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  3. Diarrhoea

50-59:

n/a

60+:

  1. Pleural effusion (water on the lungs)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. General physical health deterioration (weak health status)
  4. Haemothorax (collection of blood in the pleural space (the space between the lungs and the walls of the chest))
  5. Hepatic enzyme increased
  6. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  7. Oedema peripheral (superficial swelling)
  8. Pulmonary oedema (fluid accumulation in the lungs)
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

  1. Malignant Melanoma (skin cancer rises from melancytes): 3 people, 27.27%
  2. Pleural Mesothelioma Malignant (cancer of the pleura, or the membrane that lines the lungs): 2 people, 18.18%
  3. Pain: 2 people, 18.18%
  4. Oedema (fluid collection in tissue): 2 people, 18.18%
  5. Nausea And Vomiting: 2 people, 18.18%
  6. Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 18.18%
  7. High Blood Pressure: 2 people, 18.18%
  8. Constipation: 2 people, 18.18%
  9. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 2 people, 18.18%
  10. Prostate Cancer: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Dasatinib and Zocor?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dasatinib and Zocor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dasatinib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zocor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dasatinib and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zocor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on dasatinib and simvastatin (the active ingredients of Dasatinib and Zocor, respectively), and Dasatinib and Zocor (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: